Document is current
Any future updates will be listed below
-
Authors
Hochmair, Janine
van den Oetelaar, Maxime C. M.
Ravatt, Leandre
Diez, Lisa https://orcid.org/0000-0003-3101-0191
Lemmens, Lenne J. M.
Ponce-Lina, Renata https://orcid.org/0000-0001-9000-4563
Sankar, Rithika
Franck, Maximilian
Nolte, Gesa
Semenova, Ekaterina
Mohapatra, Satabdee https://orcid.org/0000-0002-1885-9791
Ottmann, Christian https://orcid.org/0000-0001-7315-0315
Brunsveld, Luc https://orcid.org/0000-0001-5675-511X
Wegmann, Susanne https://orcid.org/0000-0002-5388-2479
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (419138680)
Gemeinnützige Hertie-Stiftung (P1200002)
- License Information
-
More Information
Article History
Received: 14 June 2025
Accepted: 16 July 2025
First Online: 31 July 2025
Competing interests
: Christian Ottman and Luc Brunsveld are both co-founders of Ambagon Therapeutics. Christian Ottmann is currently employee and Luc Brunsveld is currently advisor of Ambagon Therapeutics.
